What Is NPH Insulin?

NPH insulin is an older type of synthetic insulin that helps people with diabetes control their blood sugar. It’s typically injected once or twice a day at regular times and is designed to deliver a steadier release of the drug over a longer period of time than faster-acting insulin.
NPH insulin has a less steady effect than newer types of long-acting insulin, and may carry more risk of low blood sugar. It can still be an effective component of diabetes care, and is generally available at a lower price and without a prescription.
How Does NPH Insulin Work?
“In people without diabetes, a small amount of insulin is released throughout the day to keep the blood glucose at a steady level," says Joshua J. Neumiller, PharmD, CDCES, president of healthcare and education at the American Diabetes Association. “To mimic this, people with type 1 diabetes and many people with type 2 diabetes take basal insulins to keep the blood glucose steady throughout the day. NPH insulin can be used twice daily to achieve this goal.”
“There is little difference between these products, and if people switch from one product to another, they typically will not notice a difference,” says Dr. Neumiller.
NPH Insulin vs. Long-Acting Insulin
“The main challenges with NPH insulin are the need to inject it more frequently and the increased risk for hypoglycemia when compared to newer long-acting insulins,” says Neumiller.
“Newer long-acting insulin products have a relatively flat glucose-lowering effect, but NPH does have a discernible peak effect and it tends to wear off before the next dose is given,” says Neumiller. “This can lead to additional variability in its action relative to newer long-acting insulins.”
What Are the Benefits of NPH Insulin?
NPH insulin is considered inferior to newer basal insulins, but some people still use it because they’re comfortable with the familiarity of it. It also is available in premixed formulations, which can be convenient.
“It can also be mixed with regular insulin in the same syringe and is well understood by many longtime users,” says Tom Wadsworth, PharmD, an associate professor and the dean of L.S. Skaggs College of Pharmacy at Idaho State University in Pocatello.
NPH insulin is also available in pharmacies without a prescription, but you won’t find it on the store shelves: You need to ask the pharmacist for it. Because it’s more affordable and accessible, some people who use insulin to manage diabetes use it as a backup option if they find themselves without access to their usual supplies.
If you’re switching between NPH insulin and a newer long-acting insulin, you will need to adjust your dosage and injection timing. NPH insulin should only be used under the care of a diabetes healthcare provider
What Are the Possible Side Effects of NPH Insulin?
One of the biggest concerns of NPH insulin is the risk for low blood sugar, and Wadsworth says it requires strict attention to timing and food intake to help prevent that from happening.
- Low potassium, which can lead to abnormal heart rhythms and fatigue
- Allergic reactions, including swelling in the face and neck or skin rashes
- Weight gain
- Scar tissue at the injection site
The Takeaway
- NPH insulin is an intermediate-acting, man-made insulin used to manage blood sugar levels. It’s an older formulation than other insulin medications, and it’s typically taken twice a day.
- Unlike newer, long-lasting insulins, NPH has a peak effect and a shorter duration of effectiveness, which requires stricter dosage timing and poses a higher risk of low blood sugar. But it is a safe and effective medicine if used properly.
- NPH insulin is more affordable than newer medications, and it can be purchased at a pharmacy without a prescription.
Resources We Trust
- Cleveland Clinic: Diabetes Mellitus Treatment
- Mayo Clinic: Insulin and Weight Gain: Keep the Pounds Off
- American Diabetes Association: Insulin Basics for Diabetes
- National Institute of Diabetes and Digestive and Kidney Diseases: Fasting Safely With Diabetes
- Association of Diabetes Care & Education Specialists: How to Inject Insulin
- Saleem F et al. NPH Insulin. StatPearls. June 12, 2023.
- Rafi E et al. Navigating Insulin Options for Diabetes Management. Journal of Clinical Endocrinology and Metabolism. February 25, 2025.
- Health & Wellness Insulin Basics for Diabetes. American Diabetes Association.
- Humulin-N-USPI Highlights of Prescribing Information. Eli Lilly and Company. 2022.
- Product Patents. Novo Nordisk.
- Sarkar S et al. Trends in Insulin Types and Devices Used by Adults With Type 2 Diabetes in the United States, 2016 to 2020. JAMA Network Open. October 12, 2021.
- Leading the Fight for Insulin Affordability. American Diabetes Association.
- Delahanty LM et al. Patient Education: Type 1 Diabetes and Diet (Beyond the Basics). UpToDate. February 19, 2025.
- Isophane Insulin (NPH) Injection. Cleveland Clinic.
- Insulin Human Isophane (NPH) (Subcutaneous Route). Mayo Clinic. February 1, 2025.
- Lipohypertrophy. Cleveland Clinic. April 29, 2022.
- Wexler JD. Patient education: Type 2 diabetes: Insulin treatment (Beyond the Basics). UpToDate. January, 15, 2025.

Anna L. Goldman, MD
Medical Reviewer
Anna L. Goldman, MD, is a board-certified endocrinologist. She teaches first year medical students at Harvard Medical School and practices general endocrinology in Boston.
Dr. Goldman attended college at Wesleyan University and then completed her residency at Icahn School of Medicine at Mount Sinai Hospital in New York City, where she was also a chief resident. She moved to Boston to do her fellowship in endocrinology at Brigham and Women's Hospital. She joined the faculty after graduation and served as the associate program director for the fellowship program for a number of years.

Jessica Freeborn
Author
Jessica Freeborn has worked as a health and wellness freelance writer since 2021. She is passionate about encouraging people to take control of their health and stay informed about the latest medical advancements. She has two nursing degrees and has used her healthcare experience to enhance her writing and research.
As someone with type 1 diabetes, she understands the complexities surrounding diabetes management and wants to provide people with accurate information and dispel misconceptions about diabetes treatment.